Literature DB >> 22802295

Germline VH/VL pairing in antibodies.

Narayan Jayaram1, Pallab Bhowmick, Andrew C R Martin.   

Abstract

Antibodies are key molecules of the adaptive immune response and are now a major class of biopharmaceuticals. Pairing of heavy and light chains is one of the ways of generating antibody diversity and, while little is known about mechanisms governing V(H)/V(L) pairing, previous studies have suggested that the germline source from which chains are paired is random. By selecting paired antibody protein sequences from human and mouse antibodies from the KabatMan database and mapping them onto their corresponding germline sequences, we find that pairing preferences do exist in the germline, but only for a small proportion of germline gene segments; others are much more promiscuous showing no preferences. The closest equivalent human and mouse gene families were identified and pairing preferences compared. This work may impact on the ability to generate more stable antibodies for use as biopharmaceuticals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802295     DOI: 10.1093/protein/gzs043

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  26 in total

1.  Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry.

Authors:  Wolfgang Schaefer; Hans R Völger; Stefan Lorenz; Sabine Imhof-Jung; Jörg T Regula; Christian Klein; Michael Mølhøj
Journal:  MAbs       Date:  2015-10-23       Impact factor: 5.857

2.  VH-VL orientation prediction for antibody humanization candidate selection: A case study.

Authors:  Alexander Bujotzek; Florian Lipsmeier; Seth F Harris; Jörg Benz; Andreas Kuglstatter; Guy Georges
Journal:  MAbs       Date:  2016       Impact factor: 5.857

3.  Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries.

Authors:  Ryan L Kelly; Doris Le; Jessie Zhao; K Dane Wittrup
Journal:  J Mol Biol       Date:  2017-11-26       Impact factor: 5.469

4.  Antibody modeling using the prediction of immunoglobulin structure (PIGS) web server [corrected].

Authors:  Paolo Marcatili; Pier Paolo Olimpieri; Anna Chailyan; Anna Tramontano
Journal:  Nat Protoc       Date:  2014-11-06       Impact factor: 13.491

Review 5.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

6.  A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization.

Authors:  Esther Drent; Maria Themeli; Renée Poels; Regina de Jong-Korlaar; Huipin Yuan; Joost de Bruijn; Anton C M Martens; Sonja Zweegman; Niels W C J van de Donk; Richard W J Groen; Henk M Lokhorst; Tuna Mutis
Journal:  Mol Ther       Date:  2017-05-13       Impact factor: 11.454

7.  A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties.

Authors:  Thomas Tiller; Ingrid Schuster; Dorothée Deppe; Katja Siegers; Ralf Strohner; Tanja Herrmann; Marion Berenguer; Dominique Poujol; Jennifer Stehle; Yvonne Stark; Martin Heßling; Daniela Daubert; Karin Felderer; Stefan Kaden; Johanna Kölln; Markus Enzelberger; Stefanie Urlinger
Journal:  MAbs       Date:  2013-04-09       Impact factor: 5.857

8.  Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires.

Authors:  Brandon J DeKosky; Oana I Lungu; Daechan Park; Erik L Johnson; Wissam Charab; Constantine Chrysostomou; Daisuke Kuroda; Andrew D Ellington; Gregory C Ippolito; Jeffrey J Gray; George Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

9.  Discovery of high affinity anti-ricin antibodies by B cell receptor sequencing and by yeast display of combinatorial VH:VL libraries from immunized animals.

Authors:  Bo Wang; Chang-Han Lee; Erik L Johnson; Christien A Kluwe; Josephine C Cunningham; Hidetaka Tanno; Richard M Crooks; George Georgiou; Andrew D Ellington
Journal:  MAbs       Date:  2016-05-25       Impact factor: 5.857

10.  Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.

Authors:  Kevin Wiehe; David Easterhoff; Kan Luo; Nathan I Nicely; Todd Bradley; Frederick H Jaeger; S Moses Dennison; Ruijun Zhang; Krissey E Lloyd; Christina Stolarchuk; Robert Parks; Laura L Sutherland; Richard M Scearce; Lynn Morris; Jaranit Kaewkungwal; Sorachai Nitayaphan; Punnee Pitisuttithum; Supachai Rerks-Ngarm; Faruk Sinangil; Sanjay Phogat; Nelson L Michael; Jerome H Kim; Garnett Kelsoe; David C Montefiori; Georgia D Tomaras; Mattia Bonsignori; Sampa Santra; Thomas B Kepler; S Munir Alam; M Anthony Moody; Hua-Xin Liao; Barton F Haynes
Journal:  Immunity       Date:  2014-11-29       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.